LISONBEE DAVID U S A,MCCAUSLAND CALVIN W U S A,BENNETT RICHARD H U S A,VAUGHAN BRENT M U S A,LEFLER SHANE M U S A
申请号：
IN1262/KOLNP/2009
公开号：
IN300928B
申请日:
2007.09.19
申请国别(地区):
IN
年份:
2018
代理人:
摘要：
Compositions that include extracts from sources of immune modulators that include nanofraction immune modulator molecules (i.e., molecules having molecular weights of about 3,000 Da and less) are disclosed. These compositions may also include other immune modulators, such as transfer factor. Administration of compositions with extracts that include nanofraction immune modulator molecules modulates the cell-mediated immunity (e.g., down-regulates undesired T cell activity) of a subject to which such compositions are administered. When administered with transfer factor, the combination of nanofraction immune modulator molecules and transfer factor down-regulates undesired T cell activity while increasing, or up-regulating, T cell activity against pathogens and other undesirable entities, such as cancer cells and other aberrant or mutated cells. Assays and assay techniques for evaluating the immune modulation capabilities of various substances are also disclosed. US2008081076A1
